Two-Year Check-Up: how well does a common biologic drug work in everyday life?
NCT ID NCT05155098
Summary
This study followed 127 adults for two years to see how well they stayed on a prescribed drug called secukinumab, which treats several related inflammatory conditions. Researchers tracked whether patients continued treatment and measured changes in their symptoms, pain, and quality of life. The goal was to understand the real-world effectiveness and benefits of this medication outside of controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Songkhla, Hat Yai, 90110, Thailand
-
Novartis Investigative Site
Muang, Thailand, 12120, Thailand
-
Novartis Investigative Site
Khon Kaen, THA, 40002, Thailand
-
Novartis Investigative Site
Bangkok, 10300, Thailand
-
Novartis Investigative Site
Bangkok, 10330, Thailand
-
Novartis Investigative Site
Bangkok, 10400, Thailand
-
Novartis Investigative Site
Bangkok, 10700, Thailand
-
Novartis Investigative Site
Chiang Mai, 50200, Thailand
-
Novartis Investigative Site
Kaen, 40000, Thailand
-
Novartis Investigative Site
Nakhon Ratchasima, 30000, Thailand
Conditions
Explore the condition pages connected to this study.